View in EDS HTML Full Text PDF Full Text

BRCA testing patterns in breast cancer over time in the United States: challenges and opportunities for improvement.

Saved in:
Bibliographic Details
Title: BRCA testing patterns in breast cancer over time in the United States: challenges and opportunities for improvement.
Authors: Mishkin K; Merck & Co., Inc., Rahway, NJ, United States., Mandal E; Thermo Fisher Scientific, Waltham, MA, United States., Tallarigo D; Thermo Fisher Scientific, Montreal, QC, Canada., Li Q; AstraZeneca, Gaithersburg, MD, United States., Casañas I Comabella C; Thermo Fisher Scientific, London, United Kingdom., Byrnes M; Thermo Fisher Scientific, Waltham, MA, United States., McCann KE; Division of Hematology/Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, United States., Moreno L; Clinical Cancer Genomics, City of Hope, Atlanta, GA, United States., Rose D; Facing Our Risk of Cancer Empowered (FORCE), Tampa, FL, United States.
Source: Frontiers in oncology [Front Oncol] 2026 Apr 27; Vol. 16, pp. 1797497. Date of Electronic Publication: 2026 Apr 27 (Print Publication: 2026).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42125683
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: BRCA testing patterns in breast cancer over time in the United States: challenges and opportunities for improvement.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mishkin+K%22">Mishkin K</searchLink>; Merck & Co., Inc., Rahway, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Mandal+E%22">Mandal E</searchLink>; Thermo Fisher Scientific, Waltham, MA, United States.<br /><searchLink fieldCode="AU" term="%22Tallarigo+D%22">Tallarigo D</searchLink>; Thermo Fisher Scientific, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Li+Q%22">Li Q</searchLink>; AstraZeneca, Gaithersburg, MD, United States.<br /><searchLink fieldCode="AU" term="%22Casañas+I+Comabella+C%22">Casañas I Comabella C</searchLink>; Thermo Fisher Scientific, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Byrnes+M%22">Byrnes M</searchLink>; Thermo Fisher Scientific, Waltham, MA, United States.<br /><searchLink fieldCode="AU" term="%22McCann+KE%22">McCann KE</searchLink>; Division of Hematology/Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Moreno+L%22">Moreno L</searchLink>; Clinical Cancer Genomics, City of Hope, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Rose+D%22">Rose D</searchLink>; Facing Our Risk of Cancer Empowered (FORCE), Tampa, FL, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Apr 27; Vol. 16, pp. 1797497. <i>Date of Electronic Publication: </i>2026 Apr 27 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42125683
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2026.1797497
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1797497
    Titles:
      – TitleFull: BRCA testing patterns in breast cancer over time in the United States: challenges and opportunities for improvement.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mishkin K
      – PersonEntity:
          Name:
            NameFull: Mandal E
      – PersonEntity:
          Name:
            NameFull: Tallarigo D
      – PersonEntity:
          Name:
            NameFull: Li Q
      – PersonEntity:
          Name:
            NameFull: Casañas I Comabella C
      – PersonEntity:
          Name:
            NameFull: Byrnes M
      – PersonEntity:
          Name:
            NameFull: McCann KE
      – PersonEntity:
          Name:
            NameFull: Moreno L
      – PersonEntity:
          Name:
            NameFull: Rose D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 04
              Text: 2026 Apr 27
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1